The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bourgeois, C.
Right arrow Articles by Stockinger, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bourgeois, C.
Right arrow Articles by Stockinger, B.
The Journal of Immunology, 2006, 177: 4558-4566.
Copyright © 2006 by The American Association of Immunologists, Inc.

CD25+CD4+ Regulatory T Cells and Memory T Cells Prevent Lymphopenia-Induced Proliferation of Naive T Cells in Transient States of Lymphopenia1

Christine Bourgeois and Brigitta Stockinger2

Division of Molecular Immunology, The National Institute for Medical Research, London, United Kingdom


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Lymphopenia has been associated with autoimmune pathology and it has been suggested that lymphopenia-induced proliferation of naive T cells may be responsible for the development of immune pathology. In this study we demonstrate that lymphopenia-induced proliferation is restricted to conditions of extreme lymphopenia, because neither naive nor memory T cells transferred into T cell-depleted hosts proliferate unless the depletion exceeds 90% of the peripheral repertoire. Memory CD4 T cells as well as regulatory CD4 T cells proved to be relatively resistant to depletion regimes, and both subsets restrict the expansion and phenotypic conversion of naive T cells by an IL-7R-dependent mechanism. It therefore seems unlikely that lymphopenia-induced proliferation of peripheral T cells causes deleterious side effects that result in immune pathology in states of partial and transient lymphopenia.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
In contrast to Ag-driven responses, the term lymphopenia-induced proliferation (LIP)3 refers to the expansion and activation of peripheral T cells in response to lymphopenia in the absence of their cognate Ags (1). This process, which has been extensively studied in experimental models in which naive T cells are transferred into hosts lacking any lymphocytes, is driven by recognition of self-peptide/MHC complexes and cytokine signaling (2). The extent of T cell expansion and the degree of phenotypic conversion are dependent on the number of cells that are transferred (3, 4). In response to lymphopenic episodes, T cell homeostasis is restored by two main pathways: thymic export and peripheral expansion. Although thymic export is the predominant source of T cell regeneration, peripheral expansion may participate in T cell restoration, especially when the thymic function is altered (5, 6). Peripheral expansion includes different mechanisms such as Ag-driven responses, basal homeostatic proliferation (or "self-renewal") of memory T cells, and lymphopenia-induced proliferation of peripheral naive T cells. Although initially considered as a pathway of T cell restoration in the periphery and consequently termed "homeostatic proliferation" (2, 7), it is now clear that T cell expansion in response to acute lymphopenia cannot restore the naive T cell pool (8, 9) because it induces activation and conversion of naive cells to an activated/memory phenotype (7, 10). Some of these memory-like cells exhibit enhanced functional activity similar to those expected for genuine memory cells (11, 12, 13). It has therefore been hypothesized that lymphopenia-induced activation of peripheral cells may participate in the development of immune or autoimmune pathology (14, 15, 16, 17, 18, 19, 20, 21, 22).

Experimental models using transfer of peripheral T cells into genetically lymphopenic hosts to study lymphopenia-induced proliferation have two major drawbacks. First, although lymphopenia-induced proliferation may occur in response to endogenous self-peptide/MHC complexes, it is clear that polyclonal T cells transferred into T cell-deficient hosts mainly react to the high load of enteric bacteria in such hosts rather than to self-peptides (23, 24). It appears that, because of the lack of T cells, genetically immunodeficient mice (such as nude, SCID, or Rag-deficient mice) cannot regulate the presentation of Ags from normal commensal bacteria. As a consequence, it is not possible to distinguish between lymphopenia-induced proliferation and environmental Ag-driven responses in experiments involving adoptive transfer of polyclonal T cells. Similarly, irradiated wild-type hosts may present higher amounts of commensal bacterial Ags due to irradiation-induced gut damage as well as the release of multiple cytokines that may influence lymphopenia-induced proliferation of adoptively transferred naive T cells (25). Second, in contrast to experimental models with genetically lymphopenic or irradiated hosts, the physiological occurrence of lymphopenia throughout an individual’s lifetime due to viral infection (26, 27, 28), therapy-related toxicity (29, 30, 31), or age-related changes (neonatal conditions (32, 33, 34) and aging) rarely results in the depletion of all peripheral T cells. However, the incidence of lymphopenia-induced proliferation and homeostasis of peripheral T cell pools under conditions of partial and transient lymphopenia have not been studied in detail. To mimic partial lymphopenic incidents, we treated normal mice with T cell-depleting Abs. This experimental setup allowed us to titrate the degree of lymphopenia to study the behavior of residual peripheral T cells as well as adoptively transferred T cells and to investigate the composition of the peripheral T cell pool following restoration of lymphopenia by thymic output. Our data show that there is no lymphopenia-induced proliferation of transferred T cells unless the degree of depletion exceeds 90% of the peripheral T cell pool. Even in severely depleted hosts, very few divisions of transferred cells were detectable, and there was no conversion to a memory-like phenotype. Any effects of residual depleting Abs on endogenous or transferred T cells was ruled out. Memory cells as well as CD25+CD4+ regulatory T cells were able to restrain the proliferation and phenotypic conversion of naive T cells via an IL-7R-dependent mechanism. This finding suggests that differential competition for this cytokine by T cell subsets usually prevents excessive proliferation and phenotypic conversion of naive T cells during states of transient lymphopenia. It is therefore unlikely that conditions of partial lymphopenia provoke excessive T cell responses to self-peptide/MHC molecules that could lead to autoimmune pathology.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Disclosures
 References
 
Mice

A1 TCR transgenic (Tg) Rag1–/– (H-2k) female mice (harboring T cells specific for the male H-Y Ag) (35) and corresponding A1 mice expressing the Thy1.1 allotype, DO11.10 TCR Tg Rag2–/– mice (H-2d) specific for the OVA peptide (36), 6.5 TCR Tg Rag 2–/– mice (H-2d) specific for an influenza hemagglutinin peptide (37), and AND TCR Tg Rag2–/– mice (H-2b) (38) as well as congenic CD45.1 AND mice between 8 and 12 wk of age were used. CBA, BALB/c, C57BL/10, IL-7–/– C57BL/10, and IL-7R{alpha}–/– C57BL/10 were used as cell donors. The corresponding syngeneic hosts used were Thy1.1 CBA and Rag1–/– H-2k, Thy1.1 BALB/c and Rag 2–/– BALB/c, and C57BL/10 and Rag1–/– B10 mice. All mice were kept under specific pathogen-free conditions, and all animal experiments were done according to institutional guidelines and Home Office (U.K.) regulations.

Depleting Abs

Anti-CD4 (YTS 191.1) and anti-CD8 (YTS 169.4.2) depleting Abs were rat IgG2b mAbs (39) prepared from cell line supernatants and purified by affinity chromatography on columns. 19E12.1 is a mouse mAb against Thy1.1 (40), and culture supernatants of this hybridoma were purified by Affigel protein A-Sepharose affinity chromatography (Bio-Rad). YTH- 89.1, a rat IgG2b Ab specific for human glycophorin (41), was used as control Ab. All depleting Ab were injected i.v.

To achieve varying degrees of depletion of peripheral T cells, we injected 6- to 8-wk-old Thy1.1 CBA mice with a mix of either anti-CD4 and anti-CD8 or anti-CD4, anti-CD8, and anti-Thy1.1 depleting Abs in different quantities. The dose dependency of depletion is shown in Fig. 1a, indicating that a single dose of 100 µg of anti-CD4 Ab per mouse is needed to deplete ~80% of the CD4 T cells, whereas as little as 50 µg of anti-CD8 Ab is sufficient for a similar degree of depletion of CD8 T cells. One hundred micrograms of anti-Thy1.1 Ab was sufficient to deplete ~80% of both the CD4 and the CD8 T cell pools. A combination of 100 µg of anti-CD4, 50 µg of anti-CD8, and 25 µg of anti-Thy1.1 Abs was used to achieve severe depletion of >90% of peripheral T cells, whereas the lower depletion regime used 50 µg of anti-CD4 and 12.5 µg of anti-CD8 Abs. Limited doses of anti-Thy1.1 Abs were used because this Ab has a slight effect on thymic cellularity, whereas anti-CD4 and anti-CD8 Ab doses as high as 200 µg per mouse and 100 µg per mouse, respectively, had no effect on thymus cellularity or subpopulations (Fig. 1b). ELISA measurements of residual depleting Abs were done using a coating goat anti-rat IgG Ab, followed by the addition of test sera and development with alkaline phosphatase-conjugated mouse anti-rat IgG.


Figure 1
View larger version (29K):
[in this window]
[in a new window]
  		FIGURE 1. Characteristics of depletion induced by depleting Ab. a, Dose-dependent effects of depleting Abs on peripheral CD4 and CD8 T cell numbers 3 days after treatment with anti-CD4 (left panel), anti-CD8 (middle panel), and Ab mix (right panel) treatment. Results are expressed as the percentage of numbers recovered in control nondepleted mice. Gray bars represent the CD4 subset, and open bars represent the CD8 subset. b, Percentage of residual double positive (DP) thymocytes after different doses of depleting Abs. Results are expressed as the percentage of numbers recovered compared with those of control nondepleted mice. c, CD8-depleting Ab (top panel) or control Ab (bottom panel) was injected into Rag-deficient (Rag neg) hosts followed 2 days later by injection of 0.5 106 CFSE-labeled 6.5 Tg CD4 T cells. CFSE profiles were analyzed 7 days after transfer. d, Correlation between the intensity of depletion and the frequency of CD44high T cells assessed 24 h after depletion.

 
Cell suspension, flow cytometry, and cellularity determinations

Lymph node (axillary, inguinal, and mesenteric) and spleen cell suspensions were prepared in IMDM (Sigma-Aldrich). Cells were stained using the usual procedures with the following: allophycocyanin- and PE-CD4 (GK1.5); allophycocyanin- and FITC-TCR (H57-597); PE-CD44; biotinylated and PE-Mel-14 and CD69; allophycocyanin-, PE-, and FITC-CD8 (53.6.7); biotinylated and PE-Thy1.2; PE-Thy1.1, allophycocyanin-IL-7Ra, and allophycocyanin-IgG2a isotype control. Streptavidin-PerCP was used to develop biotinylated Abs. All Abs were purchased from BD Pharmingen. Flow cytometry was performed with a FACSCalibur cytometer (BD Biosciences), and data files were analyzed using FlowJo software (Tree Star).

Cell sorting was performed on a MoFlo cell sorter (DakoCytomation) using previously purified suspensions with autoMACS beads: CD25-expressing cells were selected by CD25 PE staining and PE beads before sorting; naive and memory CD4 T suspensions were derived from the CD25– fraction and positively selected for CD4. Cell sorting was based on CD4, CD44, and CD62 ligand staining for the naive and memory CD4 T cell polyclonal population and on CD4, CD25, and CD44 staining for the CD25+CD4+ regulatory T cell population. Cell numbers were obtained using a Scharf Instruments Casy Counter. The total number of T cells of each phenotype in each organ was calculated from the frequency determined by FACS analysis and the total number of cells recovered from each organ. The total number of T cells recovered from the peripheral pools was considered equal to that from spleen, pooled lymph nodes, and peritoneal cavity.

Generation of memory A1 T cells

Lymph node cells from A1 Rag1–/– female mice were transferred together with syngeneic bone marrow-derived dendritic cells pulsed with 1 µM H-Y peptide into syngeneic adoptive hosts by i.v. injection as previously described (42). Dendritic cells were generated from bone marrow cultures with GM-CSF (43). Memory T cells were harvested starting 6 wk after transfer.

Polyinosinic:polycytidylic acid (poly(I:C)) treatment

Three hundred micrograms of poly(I:C) sodium salt (Sigma-Aldrich) diluted in PBS were injected i.p per mouse.

CFSE labeling

Cell division was assessed by CFSE labeling (Molecular Probes) using standard methods. Cells were resuspended in PBS in a concentration of 107/ml and incubated with CFSE at final concentration of 2.5 µM for 10 min at 37°C, followed by two washes in IMDM medium containing 10% FCS. Labeled cells were i.v. injected into syngeneic recipients.

Foxp3 intracellular staining

Forkhead box P3 (Foxp3) staining was performed using the PE Foxp3 staining set (FJK-16s Ab) (eBioscience), as described in the protocol.

Statistical analysis

All p values were obtained using THE Mann-Whitney two-tailed t test.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Disclosures
 References
 
Characteristics of T cell depletion induced by treatment with T cell depleting antibodies

To assess the consequences of different degrees of lymphopenia on homeostasis in peripheral T cell compartments, we treated mice with different combinations of Abs to achieve partial depletion of ~50% of peripheral T cells or severe depletion of 90% of T cells (described in Materials and Methods and Fig. 1a). T cell differentiation in the thymus was not affected (Fig. 1b). Furthermore, a potential effect of depleting Abs on dendritic cells, in particular the CD8+ subset of dendritic cells, was not apparent because the transfer of TCR Tg T cells into Rag-deficient hosts that had been pretreated with anti-CD8 Abs showed equivalent division potential (Fig. 1c).

The peripheral lymphopenia induced by T cell-depleting Abs was transient in both cases, because peripheral T cell numbers recovered between 20 and 60 days after depletion, depending on the initial intensity of depletion (Fig. 2a). As shown in Fig. 2b, Ab treatment preferentially deleted naive T cells, such that only 6% of the original number of naive T cells remained 3 days after the severe depletion regime, whereas 28% of memory cells and 36% of regulatory T cells survived. The preferential loss of naive T cells resulted in a shift in favor of activated/memory phenotype T cells expressing high levels of CD44 (Fig. 1d). This shift was already detectable 18 h after depletion (data not shown), confirming the differential sensitivity of T cell subsets to depletion rather than the selective proliferation of peripheral T cells with an activated phenotype. Similar observations of the preferential depletion of naive T cells compared with that of activated T cells under a number of conditioning regimes resulting in loss of T cells have been reported previously (44, 45, 46). CD25+CD4+ regulatory T cells, like memory T cells, were more resistant to Ab-mediated depletion and are therefore present in higher proportions in the peripheral T cell pool during a lymphopenic episode (as shown in Fig. 2b). The relative resistance of this T cell subset to various conditioning regimes (29, 47), as well as depletion by HIV infection (48, 49), has been reported previously.


Figure 2
View larger version (24K):
[in this window]
[in a new window]
  		FIGURE 2. T cell restoration following Ab treatment. a, Total T cells recovered from lymph nodes and spleens following treatment with low doses of anti-CD4 and anti-CD8 (0.025 and 0.0125 mg per mouse, respectively) (open circles) or a mix of high doses of anti-CD4, anti-CD8, and anti-Thy1.1 Abs (0.1, 0.05, and 0.05, respectively) (black circles). T cell numbers were assessed on days 5, 8, 15, and 21 after T cell depletion. Mean values and SD for three mice per time point are shown. Stippled lines represent the mean value ± SD of T cell numbers in control Ab-treated mice. The experiment has been repeated three times with similar results. b, Naive, memory, and regulatory T cell numbers recovered from partially (left panels) or severely (right panels) depleted hosts. Mean values and SD for three mice per time point are shown. The experiment was repeated three times with similar results.

 
Lymphopenia-induced proliferation of naive CD4 T cells is minimal in partial lymphopenia

Extrapolation from experimental models of lymphopenia in fully T cell-deficient mice would suggest that the transfer of CFSE-labeled T cells into hosts rendered partially lymphopenic by Ab-mediated T cell depletion would result in some degree of division. To study the proliferation of adoptively transferred naive peripheral T cells, we injected them into Thy1.1 congenic CBA mice that had been pretreated with either isotype control Ab (T cell-replete host) or with different doses of anti-CD4, anti-CD8, and anti-Thy1.1 depleting Abs to achieve low or severe depletion of peripheral T cells. Rag-deficient hosts were used as positive controls for complete lymphopenia. FACS-sorted naive polyclonal Thy1.2 CD4 and CD8 T cells or Tg Thy1.2 CD4 T cells were CFSE labeled and transferred into the different hosts categorized as follows: "nondepleted" (100% residual T cells); "low depletion" (45% residual T cells); "high depletion" (10% residual T cells); and "Rag-deficient hosts" (0% T cells). The intensity of depletion was determined by sacrificing mice in each group and counting the peripheral T cells recovered from lymph nodes and spleen on the day of CFSE T cell injection. The proliferative response of naive CD4 or CD8 T cells from wild-type mice was assessed 12 days after transfer. Data shown in Fig. 3, a and b, indicate that the depletion of 50% of T cells induced only minimal proliferation of polyclonal naive T cells. In highly depleted hosts (90%) few divisions were detectable, but the majority of the naive T cells that were injected had divided less than twice irrespective of whether the naive cells were CD4 (Fig. 3a) or CD8 (Fig. 3b), which generally have been shown to exhibit a higher proliferative capacity (50). Furthermore, none of the dividing T cells changed their naive phenotype (Fig. 3e). In contrast and as previously described, polyclonal naive T cells transferred into Rag-deficient hosts had undergone extensive division by day 12 after transfer, resulting in a large pool of cells that had completely lost the CFSE label. However, the transfer of polyclonal CD4 T cells into Rag-deficient hosts does not allow distinction between the relative roles of environmental Ag compared with self-peptide/MHC complexes in proliferation. We therefore performed similar experiments with monoclonal A1 or AND TCR Tg CD4 T cells (Fig. 3, c and d), which do not encounter their cognate Ags in the adoptive host and therefore proliferate only in response to self-peptide/MHC complexes. As reported previously, A1 TCR Tg CD4 T cells divide very slowly, whereas AND TCR Tg CD4 T cells divide extensively in response to lymphopenia. Because of different proliferative capacities, CFSE profiles were determined on day 15 for hosts that had received CFSE-labeled A1 T cells and on day 7 for hosts of AND T cells. Similarly as polyclonal CD4 T cells and independently of their intrinsic proliferative capacity, no more than one division of both Tg T cell populations was observed when the host contained 50% residual peripheral T cells. More T cell proliferation was detectable in highly T cell-depleted hosts, but it was still considerably lower than the proliferation observed in Rag-deficient hosts and was not associated with conversion toward a memory-like phenotype as assessed by CD44 expression (data not shown).


Figure 3
View larger version (34K):
[in this window]
[in a new window]
  		FIGURE 3. Lymphopenia-induced proliferation of adoptively transferred T cells is minimal in partially depleted hosts. Thy1.1 hosts were injected with either control anti-glycophorin Ab (aGlycoAb) (left column), low (second column from left), or high (third column from left) concentrations of anti-CD4, anti-CD8, and anti-Thy1.1 Abs. Rag-deficient hosts (right column) were used as fully T cell-deficient recipients. Three days after Ab treatment, 1 x 106 CFSE-labeled Thy1.2 peripheral T cells were transferred to sorted polyclonal naive CD4 T cells (a), sorted polyclonal naive CD8 T cells (b), naive A1 TCR Tg T cells (c), and naive AND TCR Tg T cells (b). CFSE profiles and T cell recovery shown for each T cell population were obtained 12 days after transfer for sorted polyclonal CD4 and CD8 T cells and AND Tg CD4 T cells and 15 days after transfer for A1 Tg CD4 T cells. These data are representative of two or three experiments using two or three mice per group for each experiment. e, CD44 expression was correlated with CFSE on sorted polyclonal naive CD4 T cells after transfer into different depleted hosts and Rag-deficient hosts as described above. f and g, Sorted CD44high polyclonal CD4 (f) and CD8 T cells (g) were labeled with CFSE and transferred into the different Ab-depleted hosts as described above. CFSE profiles and the T cell recovery shown for each subset were obtained 12 days after transfer. These data are representative of two or three experiments using two or three mice per group for each experiment.

 
We also tested the proliferative capacity of polyclonal CD4 and CD8 memory phenotype T cells in depleted hosts, because it was possible that memory T cells would have higher expansion capacity and might therefore be more sensitive to the available space created by T cell depletion. However, like their naive counterparts, memory phenotype T cells also failed to proliferate in partially depleted hosts (Fig. 3, f and g).

A potential problem for these experiments could be the persistence of depleting Abs in the adoptive hosts, which might subsequently affect the proliferative potential of transferred T cells. To test how long depleting Abs remain detectable in the circulation, we tested sera from mice injected with depleting Abs or control Abs. As shown in Fig. 4a, sera from mice that had received low-dose depleting Abs contained detectable amounts of Ab only 6 h after injection. With the high-depletion dose, some Ab was still detectable 3 days after injection, but not 6 days later. In contrast, control Abs that did not bind to any target cells in these mice were readily detectable at all time points tested. We further assessed the levels of surface bound Ab on endogenous T cells. Depleting Abs were detectable beginning 6 h after injection, but their detection gradually declined over the next 4 days. Recipients of the low-depleting dose no longer showed any surface bound Ab on day 3 after injection, whereas in recipients of the high-depleting dose, cell-bound Ab became undetectable by day 4 after injection. (Fig. 4b). To assess the proliferative capacity of residual T cells that were not depleted, naive T cells isolated from mice 3 days after injection of high-dose depleting Abs were CFSE labeled and transferred into Rag-deficient hosts. They proliferated to the same extent as naive T cells from control mice injected with control Ab when transferred into Rag-deficient hosts (Fig. 4c). This finding clearly indicates that there is no adverse effect of any residual Ab on the residual endogenous T cell population. To directly assess whether there is any free Ab in the circulation that would bind to the surface of adoptively transferred T cells, we adoptively transferred naive A1 T cells into hosts injected with a high-depleting dose of Ab 3 days previously and measured surface bound Ab levels 24 h later. No trace of depleting Abs was detectable on the transferred T cells (Fig. 4d). We therefore feel confident that the absence of lymphopenia-induced proliferation in partially lymphopenic hosts is not effected by the T cell-depleting Abs.


Figure 4
View larger version (26K):
[in this window]
[in a new window]
  		FIGURE 4. No residual effects of depleting Abs beyond 3 days after injection. a, ELISA detection of residual Abs in sera of mice injected with low depletion mix, high depletion mix, control anti-glycophorin Ab, or noninjected mice. Three time points are given for each group: 6 h (black filled bars), day 3 (d3; gray filled bars), and day 6 (d6; open bars) after depleting Ab injection. b, Detection of cell surface-bound depleting Ab (rat IgG2b) on endogenous CD4 T cells 6, 48, 72, and 96 h after injection of low-depletion (left column) or high-depletion Ab mix (right column). Open histograms represent control Ab-injected hosts. c, Proliferative capacity of residual naive T cells from hosts injected with high-depleting Ab mix or control Ab 3 days previously. CFSE-labeled, sorted naive CD4 T cells (1 x 106) recovered from the depleted or control hosts were transferred into Rag-deficient hosts. CFSE profiles were analyzed 8 days later. These data are representative of two experiments using four mice per group. d, Transfer of 1 x 106 A1 Ly5.1 CD4 T cells into either Ab-depleted Ly5.2 hosts (low- as well as high-depletion mix) or control Ab-treated Ly5.2 hosts. A1 T cells were recovered 24 h later and tested for cell surface-bound rat IgG2b Ab. Filled histograms represent the depleting Ab-treated hosts, and stippled lines represent the control Ab-treated hosts. These data are representative of three experiments using two or three mice per group for each experiment.

 
Partial and transient lymphopenia induced as a consequence of viral or bacterial infections is likely to be accompanied by substantial inflammation. To address the possibility that inflammatory signals are needed for lymphopenia-induced proliferation of naive T cells, we treated T cell-depleted hosts with poly(I:C) at the time of adoptive transfer of CFSE-labeled naive T cells. Transfer of polyclonal naive CD4 T cells into Ab-depleted hosts in the presence of an inflammatory signal elicited by poly(I:C) did not result in increased expansion of the transferred T cells (Fig. 5).


Figure 5
View larger version (20K):
[in this window]
[in a new window]
  		FIGURE 5. No influence of inflammatory signals on lymphopenia-induced proliferation. Using the same protocol of depletion described in Fig. 2, 1 x 106 CFSE-labeled sorted naive Thy1.2 CD4 T cells were transferred into hosts exhibiting different degrees of depletion: no T cell depletion (aGlyco Ab, anti-glycophorin Ab) (left column), low depletion (middle column), and high depletion (right column). At the time of T cell transfer some hosts (bottom row) received one injection of poly(I:C) (300 µg/mouse), whereas the other group of mice did not receive poly(I:C) (top row). CFSE profiles were analyzed 12 days after transfer. These data are representative of two experiments using four mice per group.

 
Thus, our data show that the incidence of lymphopenia-induced proliferation of naive and memory CD4 and CD8 T cells is marginal under conditions of transient partial or even substantial depletion and does not increase in the presence of inflammatory signals. This finding suggests that lymphopenia-induced proliferation of naive T cells is curbed by the presence of a small number of residual peripheral T cells that resisted depletion by Ab.

Memory and regulatory T cell subsets inhibit LIP of naive T cells

We have previously demonstrated that memory CD4 T cells are able to reduce the extent of lymphopenia-induced proliferation of naive CD4 T cells in T cell-deficient hosts. This was observed either when naive and memory CD4 T cells were cotransferred into T cell-deficient hosts or when naive T cells were transferred into hosts containing only a memory pool. Furthermore, the inhibition did not depend on naive and memory T cells sharing the same antigenic specificity (51). However, CD25+CD4+ regulatory T cells similar to memory T cells are also present in higher proportions in the peripheral T cell pool during a lymphopenic episode. To test whether CD25+CD4+ T cells, like CD4 memory T cells, inhibit lymphopenia-induced proliferation of naive T cells, we transferred CFSE-labeled DO11.10 TCR Tg CD4 T cells into Rag-deficient hosts on their own, with sorted polyclonal CD25+CD4+ T cells, or with sorted polyclonal memory CD4 T cells. The CFSE profiles obtained 10 days after transfer showed that cotransfer of CD25+CD4+ T cells or memory CD4 T cells stalled the division of naive DO.11.10 T cells, with ~50% remaining undivided compared with 7% when transferred on their own (Fig. 6a). Based on the recovery of the naive T cell input, CD25+CD4+ T cells and memory T cells had similar inhibitory potential (Fig. 6b).


Figure 6
View larger version (21K):
[in this window]
[in a new window]
  		FIGURE 6. Lymphopenia-induced proliferation of peripheral T cells is reduced in the presence of memory (+ Mem) or regulatory CD25+CD4+ T (+ CD25) cells. a, CFSE profiles obtained 15 days after transfer of 1.5 x 106 naive DO11.10 Tg CD4 T cells into BALB/c Rag-deficient hosts either alone (left panel), with polyclonal sorted Thy1.1 memory CD4 T cells (middle panel), or with polyclonal sorted Thy1.1 CD25+CD4+ T cells (right column) in a 2:1 ratio. b, DO11.10 T cell numbers from lymph nodes and spleens 15 days after transfer. This experiment is representative of three experiments using two or three mice per group and per time point.

 
Competition for IL-7 underlies the inhibition of LIP

Because lymphopenia-induced proliferation of naive T cells has been shown to depend on the availability of IL-7 (52, 53, 54, 55), we determined the respective inhibitory effect of memory or CD25+CD4+ T cells from IL-7R-deficient or -competent hosts on the lymphopenia-induced proliferation of naive CD4 T cells. Although IL-7R-deficient mice show severe deficiency of T cell selection in the thymus and have few if any naive T cells in the periphery, they do contain memory phenotype T cells as well as T cells with a regulatory phenotype (56).

To test the inhibitory capacity of both memory and regulatory T cells separately, we first transferred CFSE-labeled AND TCR Tg CD4 T cells expressing the CD45.1 allotype into Rag-deficient hosts either alone or with sorted IL-7R-deficient or competent memory CD45.2 CD4 T cells. Fig. 7a shows that 8 days after transfer, ~30% of the transferred AND T cells had undergone more than seven divisions when transferred alone or cotransferred with IL-7R-deficient memory T cells. In contrast, the presence of IL-7R-competent memory cells reduced their proliferation such that only 9% of transferred AND T cells divided >7 times. The recovery of AND T cells transferred with wild-type memory cells was substantially reduced in agreement with their reduced proliferative capacity, whereas similar numbers of AND T cells were recovered following transfer on their own compared with cotransfer of IL-7R-deficient memory cells (Fig. 7b, left panel). The failure of IL-7R-negative memory cells to inhibit was not due to their own lower proliferative capacity, because 8 days after transfer similar numbers of IL-7R-deficient and -competent competitors were recovered from the adoptive hosts (Fig. 7b, right panel). It is also unlikely that the disrupted lymphoid architecture in IL-7R-deficient mice and the resulting potential defect in T cell selection and development are responsible for the failure of IL-7R-deficient memory T cells to inhibit lymphopenia-induced expansion, because T cells from IL-7 cytokine-deficient hosts, which have similar defects in T cell selection and development but express IL-7R, were as inhibitory as wild-type memory T cells (data not shown).


Figure 7
View larger version (24K):
[in this window]
[in a new window]
  		FIGURE 7. Competition for IL7 underlies the inhibition of lymphopenia-induced proliferation. a and b, CFSE-labeled CD5.1 AND Tg CD4 T cells (0.5 x 106) were transferred alone or cotransferred in a 2:1 ratio with sorted polyclonal memory Ly 5.2 CD4 T cells from either IL-7R-deficient (+ IL7R– Mem) or IL-7R wild-type donors (WT Mem). a, CFSE profiles of AND Tg naive T cells are shown 8 days after transfer. b, T cell recovery of both naive AND T cells (left panel) and the respective memory competitor subsets (right panel) is shown. This figure is representative of three experiments using two or three mice per group. c and d, CFSE-labeled CD45.1 AND Tg CD4 T cells (0.5 x 106) were transferred alone or cotransferred in a 2:1 ratio with sorted polyclonal CD25+ CD4+ regulatory T cells from either IL-7R-deficient or IL-7R wild-type donors into Rag-deficient hosts. c, CFSE profiles of AND Tg naive T cells are shown 8 days after transfer. d, T cell recovery 8 days after transfer of both naive AND T cells (left panel) and the respective competitor subsets (right panel) is shown. This figure is representative of three experiments using two mice per group. e, CFSE-labeled CD45.1 AND TCR Tg CD4 T cells (1 x 106) were transferred into Rag-deficient (Rag neg; left column), IL-7R-deficient (IL7R–; middle column), or Ab depleted (high depletion mix) wild-type hosts (depleted WT; right column). CFSE profiles of AND Tg naive T cells are shown 6 days after transfer. This figure is representative of two experiments using two mice per group.

 
We next tested the inhibitory capacity of CD25+CD4+ T cells isolated from IL-7R-deficient hosts. CFSE-labeled CD45.1-expressing AND T cells were transferred into Rag-deficient hosts alone or with sorted IL-7R-deficient or -competent CD25+CD4+ T cells. The CFSE profile of AND T cells was analyzed 8 days after transfer. The cotransfer of CD25+CD4+ regulatory cells from wild-type mice reduced the fraction of AND T cells that had undergone more than seven divisions from 35 to 7%, whereas AND T cells cotransferred with CD25+CD4+ T cells from IL-7R-deficient donors divided as extensively as those transferred on their own (Fig. 7c). Recovery (Fig. 7d) of the naive AND T cell input was lower in the presence of wild-type CD25+CD4+ T cells compared with CD25+CD4+ T cells from IL-7R-deficient hosts (p = 0.03), whereas the recovery of the competitor cells was not significantly different whether they were derived from IL-7R-deficient or wild-type hosts (p = 0.19).

To address the issue of an IL-7R requirement in a more physiological context that does not involve cotransfer into T cell-deficient hosts, we injected AND T cells directly into either IL-7R-deficient hosts or Ab-depleted wild-type hosts. Rag-deficient mice served as an additional control. IL-7R-deficient hosts contained similar numbers of regulatory T cells and memory T cells (1.12 x 106 and 5.45 x 106, respectively) as Ab-depleted wild-type hosts (1 x 106 and 4.2 x 106). Nevertheless, AND T cells only divided in IL-7R-deficient hosts, similarly as Rag-deficient hosts, whereas they underwent only one division in Ab-depleted wild-type hosts (Fig. 7e). This finding supports the conclusion that neither memory nor regulatory T cells are able to inhibit lymphopenia-induced expansion if they cannot compete for IL-7.

To address whether the CD25+CD4 T cells recovered were genuine regulatory T cells rather than effector-like T cells, we performed intracellular staining for Foxp3. IL-7R-deficient CD25+CD4+ T cells expressed similar levels of Foxp3 as wild-type CD25+CD4+ T cells (Fig. 8a). Although the percentage of CD25+CD4+ regulatory T cells was higher in IL-7R-deficient mice because those mice lack naive T cells (56), absolute numbers were lower in IL-7R-deficient mice compared with wild-type mice (Fig. 8b). The data shown in Fig. 6 indicate that CD25+CD4+ regulatory T cells as well as memory T cells inhibit lymphopenia-induced expansion of other T cells by an IL-7R-dependent mechanism. This finding was unexpected in the case of CD25+CD4+regulatory T cells, because these cells are reported to express relatively low levels of IL-7R. We therefore investigated the levels of IL-7R expression on naive, memory, and CD25+CD4+regulatory T cells during the state of partial lymphopenia in mice that had undergone T cell-depletion regimes. CBA mice were depleted of ~50 or 90% of their peripheral T cells, and IL-7R levels were determined on the residual T cell populations 7 days later. As shown in Fig. 7c, both the naive and the memory CD4 T cells that remained following Ab-mediated depletion down-regulated IL-7R expression as compared with their counterparts in mice treated with control Abs. CD25+CD4+ regulatory T cells, in contrast, maintained a low but constant expression of IL-7R that did not change upon partial or severe depletion. Thus, IL-7R dependency of inhibition by regulatory T cells is conceivable, as they express similar levels of this receptor as both naive and memory T cells in a state of partial lymphopenia.


Figure 8
View larger version (24K):
[in this window]
[in a new window]
  		FIGURE 8. Foxp3 expression in CD25+CD4+ T cells and IL-7R regulation. a, Intracellular staining for Foxp3 on IL-7R-deficient (IL7R–; upper panel) and wild-type (WT; lower panel) splenic CD4+TCR+ T cells is shown. These profiles are representative of three experiments analyzing three individual mice per group. b, CD25+CD4+ T cell recovery from spleens of IL-7R-deficient and wild-type mice. The data shown are representative of three experiments analyzing three individuals per group. c, Following Ab depletion as described in Fig. 2, IL-7R expression was assessed 7 days later on naive (upper graph), memory (middle graph), and CD25+CD4+ T cells (lower graph) recovered from nondepleted wild-type (thick black line), partially depleted (dotted gray line), and highly depleted hosts (gray shaded profile). The isotype control staining for each of these populations is represented by the thin dotted line.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Disclosures
 References
 
Although the principles and mechanisms underlying the effects of lymphopenia on the behavior of peripheral T cells are mainly investigated in experimental models of extreme lymphopenia, episodes of transient lymphopenia will rarely reach such intensity of lymphocyte depletion. Bacterial and viral infections do not cause the loss of >50% of peripheral T cells (26, 27, 28, 57). Although aging is associated with a certain degree of lymphopenia due to the loss of T cell production by the thymus, the effect is not that drastic (51). The lymphopenia observed in NOD mice genetically disposed to develop diabetes is also not comparable with that seen in T cell-deficient hosts (18). During a short time frame in the neonatal phase, T cells seeding the periphery will encounter a severely lymphopenic environment, but the effect of lymphopenia-induced proliferation during this short time period remains unclear and appears minor overall (32, 34). Severe induction of lymphopenia may thus be restricted to clinical interventions such as radiation treatment or treatment with cytotoxic drugs that may, in addition to depleting mature peripheral T cells, also affect T cell replenishment by the thymus.

In this study we modeled partial lymphopenic incidents by treatment with T cell-depleting Abs. Surprisingly, even in a situation where 90% of peripheral host T cells had been eliminated, there was little evidence that the "space" created induced either a higher expansion of remaining T cells as assessed by analysis of BrdU incorporation (data not shown) or an expansion of adoptively transferred CFSE-labeled T cells, whether these were naive or memory phenotype. The lack of expansion of transferred T cells was not due to any potential effect of residual depleting Abs, as we ascertained that there was no free Ab present at the time of T cell transfer 3 days after Ab injection. All available Abs seemed to have been sequestered by peripheral T cells, such that there were not even sufficient Abs left in the circulation to affect differentiating T cells in the thymus as judged by the fact that thymus cellularity and composition of subpopulations remained unchanged after the injection of depleting Abs.

The lymphopenia induced by T cell-depleting Abs was transient, because numbers of peripheral T cells slowly increased over a period of 4–6 wk due predominantly to thymic export in agreement with previous reports (5). There was no indication of increased proliferation of residual memory T cells in the host as a response to partial lymphopenia, suggesting that the normal slow self-renewal of the memory pool is not accelerated in conditions of partial lymphopenia. Because T cell homeostasis and lymphopenia-induced proliferation are restrained by competition for survival/proliferation factors (58), it seemed reasonable to assume that residual T cell subsets were responsible for the abrogation of lymphopenia-induced proliferation in T cell-depleted mice. Indeed, both memory and CD25+CD4+ regulatory T cells that are preserved in higher numbers than naive T cells during lymphopenic episodes curbed lymphopenia-induced proliferation of naive T cells, and this effect depended on their expression of IL-7 receptors.

Thus, although the survival of naive, memory, and CD25+CD4+ regulatory T cells under steady-state conditions depends on distinct factors, it appears that under conditions of extreme lymphopenia IL-7 becomes the dominant cytokine for which different T cell subsets compete. This finding was unexpected for CD25+CD4+ regulatory T cells, because they express lower levels of IL-7R than both naive and memory T cells in replete hosts (59), which is in agreement with their reliance on other factors such as IL-2 for their survival (60, 61). However, naive and memory T cells down-regulate IL-7R under conditions of lymphopenia, whereas IL-7R levels on regulatory T cells remain constant irrespective of the presence or absence of other T cells. The correlation between IL-7R expression levels on naive and memory T cells and the intensity of depletion further emphasizes the central role of IL-7 (54) and CD25+CD4+ T cells (62, 63) in the control of peripheral T cell homeostasis. We demonstrated here that in addition to their suppressive effect on Ag-driven responses, CD25+CD4+ regulatory T cells also inhibit lymphopenia-induced activation of peripheral T cells, but by using a different suppressive mechanism based on IL-7 competition.

Although extrapolation from experimental models of T cell transfer into T cell-deficient hosts has prompted suggestions that lymphopenia-induced proliferation might underlie loss of tolerance and development of autoimmunity, it seems that the incidence of lymphopenia-induced proliferation of naive T cells is drastically restricted in a more physiological context of lymphopenia. Furthermore, our experimental model reflects transient incidents of lymphopenia that can be corrected by continuous thymic export. Under these conditions, excessive responses to self-peptide/MHC molecules or environmental Ags do not seem to occur, thus making it unlikely that transient and partial lymphopenic incidents are predisposing for autoimmune pathology.

Deleterious effects of lymphopenia as a consequence of exacerbated expansion of effector T cells responding to pathogens or abnormally presented self-Ags (64, 65, 66) rather than the tonic stimulation of self-peptide/MHC complexes have been reported. However, in these instances also such responses were induced in T cell-deficient hosts, and there is not yet any information as to whether similar events would occur in partial and transient lymphopenia.

More extreme immune depletion protocols are used in a clinical setting with the aim of resetting the T cell repertoire to induce remission from autoimmune disease (67). It is possible that depletion regimes that spare regulatory T cells or memory T cells may be particularly successful, because these cells could potentially curb excessive pathological responses of reduced numbers of effector T cells. A remarkably successful strategy that inhibits clinical manifestations of diabetes is the treatment using anti-CD3 Abs, which, similar to the data described here, induce only partial and transient lymphopenia that appears to spare CD25+CD4+ regulatory T cells (68, 69).

Alternatively, there may be treatment regimes that affect different CD4 T cell subsets such as regulatory T cells or memory T cells, and these might have opposing effects that allow the expansion of residual endogenous cells. Whether such regimes also result in deleterious responses to abnormally presented self-Ags or pathogens remains to be determined.


   Acknowledgments
 
We thank B. Seddon and A. Potocnik for providing, respectively, the IL-7R-deficient and IL7-deficient mice, S. Cobbold for providing the hybridomas secreting depleting Abs, T. Norton, K. Williams, and H. Boyles for animal husbandry, G. Pierce and C. Atkins for cell sorting, and R. Hocking for Ab purification and technical help.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Medical Research Council U.K. Back

2 Address correspondence and reprint requests to Dr. Brigitta Stockinger, Division of Molecular Immunology, The National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, U.K. E-mail address: bstocki{at}nimr.mrc.ac.uk Back

3 Abbreviations used in this paper: LIP, lymphopenia-induced proliferation; Foxp3, Forkhead box P3; poly(I:C), polyinosinic acid:cytidylic acid; Tg, transgenic. Back

Received for publication March 31, 2006. Accepted for publication July 24, 2006.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Bell, E. B., S. M. Sparshott. 1997. The peripheral T-cell pool: regulation by non-antigen induced proliferation?. Semin. Immunol. 9: 347-353. [Medline]
  2. Goldrath, A. W., M. J. Bevan. 1999. Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity 11: 183-190. [Medline]
  3. Ernst, B., D. S. Lee, J. M. Chang, J. Sprent, C. D. Surh. 1999. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11: 173-181. [Medline]
  4. Jameson, S. C.. 2005. T cell homeostasis: keeping useful T cells alive and live T cells useful. Semin. Immunol. 17: 231-237. [Medline]
  5. Mackall, C. L., F. T. Hakim, R. E. Gress. 1997. Restoration of T-cell homeostasis after T-cell depletion. Semin. Immunol. 9: 339-346. [Medline]
  6. Modigliani, Y., G. Coutinho, O. Burlen-Defranoux, A. Coutinho, A. Bandeira. 1994. Differential contribution of thymic outputs and peripheral expansion in the development of peripheral T cell pools. Eur. J. Immunol. 24: 1223-1227. [Medline]
  7. Kieper, W. C., S. C. Jameson. 1999. Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc. Natl. Acad. Sci. USA 96: 13306-13311. [Abstract/Free Full Text]
  8. Ge, Q., H. Hu, H. N. Eisen, J. Chen. 2002. Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments. Proc. Natl. Acad. Sci. USA 99: 2989-2994. [Abstract/Free Full Text]
  9. Tanchot, C., A. Le Campion, B. Martin, S. Leaument, N. Dautigny, B. Lucas. 2002. Conversion of naive T cells to a memory-like phenotype in lymphopenic hosts is not related to a homeostatic mechanism that fills the peripheral naive T cell pool. J. Immunol. 168: 5042-5046. [Abstract/Free Full Text]
  10. Oehen, S., K. Brduscha-Riem. 1999. Naive cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients: a pitfall for T cell memory studies?. Eur. J. Immunol. 29: 608-614. [Medline]
  11. Cho, B. K., V. P. Rao, Q. Ge, H. N. Eisen, J. Chen. 2000. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J. Exp. Med. 192: 549-556. [Abstract/Free Full Text]
  12. Murali-Krishna, K., R. Ahmed. 2000. Cutting edge: naive T cells masquerading as memory cells. J. Immunol. 165: 1733-1737. [Abstract/Free Full Text]
  13. Gudmundsdottir, H., L. A. Turka. 2001. A closer look at homeostatic proliferation of CD4+ T cells: costimulatory requirements and role in memory formation. J. Immunol. 167: 3699-3707. [Abstract/Free Full Text]
  14. Bonomo, A., P. J. Kehn, E. M. Shevach. 1995. Post-thymectomy autoimmunity: abnormal T-cell homeostasis. Immunol. Today 16: 61-67. [Medline]
  15. Heath, V., D. Mason, F. Ramirez, B. Seddon. 1997. Homeostatic mechanisms in the control of autoimmunity. Semin. Immunol. 9: 375-380. [Medline]
  16. Theofilopoulos, A. N., W. Dummer, D. H. Kono. 2001. T cell homeostasis and systemic autoimmunity. J. Clin. Invest. 108: 335-340. [Medline]
  17. Prlic, M., S. C. Jameson. 2002. Homeostatic expansion versus antigen-driven proliferation: common ends by different means?. Microbes Infect. 4: 531-537. [Medline]
  18. King, C., A. Ilic, K. Koelsch, N. Sarvetnick. 2004. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117: 265-277. [Medline]
  19. Knoechel, B., J. Lohr, E. Kahn, A. K. Abbas. 2005. The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance. J. Immunol. 175: 21-26. [Abstract/Free Full Text]
  20. Baccala, R., A. N. Theofilopoulos. 2005. The new paradigm of T-cell homeostatic proliferation-induced autoimmunity. Trends Immunol. 26: 5-8. [Medline]
  21. Jang, E., H. R. Kim, S. H. Cho, D. J. Paik, J. M. Kim, S. K. Lee, J. Youn. 2006. Prevention of spontaneous arthritis by inhibiting homeostatic expansion of autoreactive CD4+ T cells in the K/BxN mouse model. Arthritis Rheum. 54: 492-498. [Medline]
  22. Marleau, A. M., N. Sarvetnick. 2005. T cell homeostasis in tolerance and immunity. J. Leukocyte Biol. 78: 575-584. [Abstract/Free Full Text]
  23. Kieper, W. C., A. Troy, J. T. Burghardt, C. Ramsey, J. Y. Lee, H. Q. Jiang, W. Dummer, H. Shen, J. J. Cebra, C. D. Surh. 2005. Recent immune status determines the source of antigens that drive homeostatic T cell expansion. J. Immunol. 174: 3158-3163. [Abstract/Free Full Text]
  24. Min, B., H. Yamane, J. Hu-Li, W. E. Paul. 2005. Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms. J. Immunol. 174: 6039-6044. [Abstract/Free Full Text]
  25. Moses, C. T., K. M. Thorstenson, S. C. Jameson, A. Khoruts. 2003. Competition for self ligands restrains homeostatic proliferation of naive CD4 T cells. Proc. Natl. Acad. Sci. USA 100: 1185-1190. [Abstract/Free Full Text]
  26. Haase, A. T.. 1999. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu. Rev. Immunol. 17: 625-656. [Medline]
  27. Permar, S. R., W. J. Moss, J. J. Ryon, D. C. Douek, M. Monze, D. E. Griffin. 2003. Increased thymic output during acute measles virus infection. J. Virol. 77: 7872-7879. [Abstract/Free Full Text]
  28. He, Z., C. Zhao, Q. Dong, H. Zhuang, S. Song, G. Peng, D. E. Dwyer. 2005. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int. J. Infect. Dis. 9: 323-330. [Medline]
  29. Cox, A. L., S. A. Thompson, J. L. Jones, V. H. Robertson, G. Hale, H. Waldmann, D. A. Compston, A. J. Coles. 2005. Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis. Eur. J. Immunol. 35: 3332-3342. [Medline]
  30. Hakim, F. T., R. E. Gress. 2005. Reconstitution of the lymphocyte compartment after lymphocyte depletion: a key issue in clinical immunology. Eur. J. Immunol. 35: 3099-3102. [Medline]
  31. Zhang, H., K. S. Chua, M. Guimond, V. Kapoor, M. V. Brown, T. A. Fleisher, L. M. Long, D. Bernstein, B. J. Hill, D. C. Douek, et al 2005. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat. Med. 11: 1238-1243. [Medline]
  32. Le Campion, A., C. Bourgeois, F. Lambolez, B. Martin, S. Leaument, N. Dautigny, C. Tanchot, C. Penit, B. Lucas. 2002. Naive T cells proliferate strongly in neonatal mice in response to self-peptide/self-MHC complexes. Proc. Natl. Acad. Sci. USA 99: 4538-4543. [Abstract/Free Full Text]
  33. Schuler, T., G. J. Hammerling, B. Arnold. 2004. Cutting edge: IL-7-dependent homeostatic proliferation of CD8+ T cells in neonatal mice allows the generation of long-lived natural memory T cells. J. Immunol. 172: 15-19. [Abstract/Free Full Text]
  34. Min, B., R. McHugh, G. D. Sempowski, C. Mackall, G. Foucras, W. E. Paul. 2003. Neonates support lymphopenia-induced proliferation. Immunity 18: 131-140. [Medline]
  35. Zelenika, D., E. Adams, A. Mellor, E. Simpson, P. Chandler, B. Stockinger, H. Waldmann, S. P. Cobbold. 1998. Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells. J. Immunol. 161: 1868-1874. [Abstract/Free Full Text]
  36. Murphy, K. M., A. B. Heimberger, D. Y. Loh. 1990. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 250: 1720-1723. [Abstract/Free Full Text]
  37. Kirberg, J., A. Baron, S. Jakob, A. Rolink, K. Karjalainen, H. von Boehmer. 1994. Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J. Exp. Med. 180: 25-34. [Abstract/Free Full Text]
  38. Kaye, J., M. L. Hsu, M. E. Sauron, S. C. Jameson, N. R. Gascoigne, S. M. Hedrick. 1989. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 341: 746-749. [Medline]
  39. Cobbold, S. P., G. Martin, H. Waldmann. 1990. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur. J. Immunol. 20: 2747-2755. [Medline]
  40. Bernstein, I. D., M. R. Tam, R. C. Nowinski. 1980. Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen. Science 207: 68-71. [Abstract/Free Full Text]
  41. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312: 548-551. [Medline]
  42. Garcia, S., J. DiSanto, B. Stockinger. 1999. Following the development of a CD4 T cell response in vivo: from activation to memory formation. Immunity 11: 163-171. [Medline]
  43. Volkmann, A., T. Zal, B. Stockinger. 1997. Antigen-presenting cells in the thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen. J. Immunol. 158: 693-706. [Abstract]
  44. Rep, M. H., B. W. van Oosten, M. T. Roos, H. J. Ader, C. H. Polman, R. A. van Lier. 1997. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-{gamma} secreting TH1 cells in humans. J. Clin. Invest. 99: 2225-2231. [Medline]
  45. Chace, J. H., J. S. Cowdery, E. H. Field. 1994. Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naive CD4 cells and spares activated CD4 cells. J. Immunol. 152: 405-412. [Abstract]
  46. Pearl, J. P., J. Parris, D. A. Hale, S. C. Hoffmann, W. B. Bernstein, K. L. McCoy, S. J. Swanson, R. B. Mannon, M. Roederer, A. D. Kirk. 2005. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am. J. Transplant. 5: 465-474. [Medline]
  47. Minamimura, K., W. Gao, T. Maki. 2006. CD4+ regulatory T cells are spared from deletion by antilymphocyte serum, a polyclonal anti-T cell antibody. J. Immunol. 176: 4125-4132. [Abstract/Free Full Text]
  48. Weiss, L., V. Donkova-Petrini, L. Caccavelli, M. Balbo, C. Carbonneil, Y. Levy. 2004. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104: 3249-3256. [Abstract/Free Full Text]
  49. Tsunemi, S., T. Iwasaki, T. Imado, S. Higasa, E. Kakishita, T. Shirasaka, H. Sano. 2005. Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients. AIDS 19: 879-886. [Medline]
  50. Ferreira, C., T. Barthlott, S. Garcia, R. Zamoyska, B. Stockinger. 2000. Differential survival of naive CD4 and CD8 T cells. J. Immunol. 165: 3689-3694. [Abstract/Free Full Text]
  51. Bourgeois, C., G. Kassiotis, B. Stockinger. 2005. A major role for memory CD4 T cells in the control of lymphopenia-induced proliferation of naive CD4 T cells. J. Immunol. 174: 5316-5323. [Abstract/Free Full Text]
  52. Schluns, K. S., W. C. Kieper, S. C. Jameson, L. Lefrancois. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1: 426-432. [Medline]
  53. Tan, J. T., B. Ernst, W. C. Kieper, E. LeRoy, J. Sprent, C. D. Surh. 2002. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J. Exp. Med. 195: 1523-1532. [Abstract/Free Full Text]
  54. Fry, T. J., C. L. Mackall. 2005. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 174: 6571-6576. [Abstract/Free Full Text]
  55. Bosco, N., F. Agenes, R. Ceredig. 2005. Effects of increasing IL-7 availability on lymphocytes during and after lymphopenia-induced proliferation. J. Immunol. 175: 162-170. [Abstract/Free Full Text]
  56. Seddon, B., P. Tomlinson, R. Zamoyska. 2003. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat. Immunol. 4: 680-686. [Medline]
  57. Cunha, B. A., B. P. McDermott, S. S. Mohan. 2004. Prognostic importance of lymphopenia in West Nile encephalitis. Am. J. Med. 117: 710-711. [Medline]
  58. Freitas, A. A., B. Rocha. 2000. Population biology of lymphocytes: the flight for survival. Annu. Rev. Immunol. 18: 83-111. [Medline]
  59. Cozzo, C., J. Larkin, III, A. J. Caton. 2003. Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J. Immunol. 171: 5678-5682. [Abstract/Free Full Text]
  60. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151. [Medline]
  61. D’Cruz, L. M., L. Klein. 2005. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6: 1152-1159. [Medline]
  62. Almeida, A. R., N. Legrand, M. Papiernik, A. A. Freitas. 2002. Homeostasis of peripheral CD4+ T cells: IL-2R {alpha} and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J. Immunol. 169: 4850-4860. [Abstract/Free Full Text]
  63. Murakami, M., A. Sakamoto, J. Bender, J. Kappler, P. Marrack. 2002. CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc. Natl. Acad. Sci. USA 99: 8832-8837. [Abstract/Free Full Text]
  64. Dummer, W., A. G. Niethammer, R. Baccala, B. R. Lawson, N. Wagner, R. A. Reisfeld, A. N. Theofilopoulos. 2002. T cell homeostatic proliferation elicits effective antitumor autoimmunity. J. Clin. Invest. 110: 185-192. [Medline]
  65. Wu, Z., S. J. Bensinger, J. Zhang, C. Chen, X. Yuan, X. Huang, J. F. Markmann, A. Kassaee, B. R. Rosengard, W. W. Hancock, et al 2004. Homeostatic proliferation is a barrier to transplantation tolerance. Nat. Med. 10: 87-92. [Medline]
  66. Gattinoni, L., S. E. Finkelstein, C. A. Klebanoff, P. A. Antony, D. C. Palmer, P. J. Spiess, L. N. Hwang, Z. Yu, C. Wrzesinski, D. M. Heimann, et al 2005. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J. Exp. Med. 202: 907-912. [Abstract/Free Full Text]
  67. Muraro, P. A., D. C. Douek. 2006. Renewing the T cell repertoire to arrest autoimmune aggression. Trends Immunol. 27: 61-67. [Medline]
  68. Belghith, M., J. A. Bluestone, S. Barriot, J. Megret, J. F. Bach, L. Chatenoud. 2003. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9: 1202-1208. [Medline]
  69. Chatenoud, L.. 2005. CD3-specific antibodies restore self-tolerance: mechanisms and clinical applications. Curr. Opin. Immunol. 17: 632-637. [Medline]



This article has been cited by other articles:


Home page
 BloodHome page
W. Jing, J. A. Gershan, and B. D. Johnson
Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory
Blood, April 30, 2009; 113(18): 4449 - 4457.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. T. Burchell, M. E. Wikstrom, P. A. Stumbles, P. D. Sly, and D. J. Turner
Attenuation of allergen-induced airway hyperresponsiveness is mediated by airway regulatory T cells
Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L307 - L319.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. L. Bayer, M. Jones, J. Chirinos, L. de Armas, T. H. Schreiber, T. R. Malek, and R. B. Levy
Host CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT
Blood, January 15, 2009; 113(3): 733 - 743.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Bourgeois, Z. Hao, K. Rajewsky, A. J. Potocnik, and B. Stockinger
Ablation of thymic export causes accelerated decay of naive CD4 T cells in the periphery because of activation by environmental antigen
PNAS, June 24, 2008; 105(25): 8691 - 8696.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Thomas-Vaslin, H. K. Altes, R. J. de Boer, and D. Klatzmann
Comprehensive Assessment and Mathematical Modeling of T Cell Population Dynamics and Homeostasis
J. Immunol., February 15, 2008; 180(4): 2240 - 2250.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Wan, H. Dai, T. Wang, Y. Moore, X. X. Zheng, and Z. Dai
Bystander Central Memory but Not Effector Memory CD8+ T Cells Suppress Allograft Rejection
J. Immunol., January 1, 2008; 180(1): 113 - 121.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bourgeois, C.
Right arrow Articles by Stockinger, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bourgeois, C.
Right arrow Articles by Stockinger, B.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS